BMGL
Basel Medical Group Ltd.
NASDAQ · Healthcare · Medical - Healthcare Plans · SG
$4.75
+3.26%Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open$4.56
From 52W high−74.79%
Volume1.32M
Market cap$36.02M
P/E (TTM)—
P/S (TTM)2.1x
Div yield—
Key dataOct 29, 2026
Open
$4.56
From 52W high
−74.79%
Volume
1.32M
Market cap
$36.02M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−14.8x
P/E (TTM)
—
RSI (14)
64.0
MomentumView details →
1D Return
+3.26%
YTD Return
−18.03%
SummaryUpdated Dec 1, 2025
Basel Medical Group Ltd (NASDAQ:BMGL) is a Singapore-based healthcare services company that was incorporated in 2023. Despite its recent incorporation, the company has been operating in the healthcare sector providing comprehensive medical services across multiple specialties. The company went public to expand its healthcare service offerings and capitalize on growing demand for integrated medical solutions in the Asia-Pacific region.
Similar companies
Latest newsMore news →
Basel Medical Group Ltd entered into agreements to issue and sell 6,000,000 units at a public offering price of US$1 per unit in a registered direct offering.21d agoBasel Medical Group Ltd received notification from Nasdaq that it has regained compliance with the Nasdaq minimum bid price rule.111d ago